What Clinical Research Sites Should Do During Coronavirus Disruptions and FDA's Guidance

During the early stages of the COVID-19 pandemic, many site were uncertain about what to prioritize. This video captures some of the early concerns about patent safety which were communicated by the FDA. Sites were quick to adapt these FDA guidelines into their own SOPs.